top of page
Accellvecs Inc. provides natural killer T (NKT) cell-activating compound, alpha-galactosylceramide (KRN7000), which is not merely reagent manufactured in accordance with GMP, but is GMP-manufactured drug substance used in human clinical trials, thus ensuring high level of safety.
Accellvecs Inc. welcome all interested parties to contact us using our form.
Company Profile
Company Name Accellvecs Inc.
Office 1-12-8, Shibuya, Shibuya-ku, Tokyo, 150-0002, Japan
Representative President & CEO Yasuyuki Ishii
Contact Us
Please click Contact Form
bottom of page